About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 8455 record(s)
Req # ATI2024-033
“I would like to have, for all periods available, for loans related to the CDAP program; 1. The number of loan requests received, per month 2. The number of loans accepted, per month 3. The number of loans refused, per month 4. Total capital loaned, per month.”Organization: Business Development Bank of Canada
April 2024
Nothing to report this month
Organization: Quebec Port Authority
Req # ATI2024-032
``“[…] We make the following requests for the period January 1, 2004 to November 30, 2023 (the "Period"), unless otherwise indicated: (1) All records related in anyway to Suncor, EDC, and Libya (2) Any communications relating to risks associated with Libya as a financial institution. (3) Any communications between EDC and the Business Development Bank of Canada that relate in any way to EDC's provision of Political Risk Insurance.”Organization: Business Development Bank of Canada
March 2024
March 2024
Req # A-2023-00068
Policy interpretations related to large virtual currency transaction reportingOrganization: Financial Transactions and Reports Analysis Centre of Canada
March 2024
Req # A-2023-00072
Various 2022 and 2023 statistics on money services businesses; relating to the amount of businesses registered, number of employees, policy interpretations requested, volume of transactions, and deficiencies found in compliance examinationsOrganization: Financial Transactions and Reports Analysis Centre of Canada
March 2024
Req # A-2023-00089
Questions, answers and interpretations concerning politically exposed personsOrganization: Financial Transactions and Reports Analysis Centre of Canada
March 2024
Req # A-2016-000420
Documents relating to Health Canada’s approval of INFLECTRA (Drug Identification Number (DIN) # 02419475): All Health Canada reviewers reports and reviewer comments; and all minutes from any pre-Supplement to a New Drug Submission (SNDS) meetings between Celltrion (health care company) and Health Canada between September 1, 2014 and June 30, 2015.Organization: Health Canada
March 2024
Req # A-2019-001464
All domestic Adverse Drug Reaction (ADR) reports for Tetanus, Diphtheria and Pertussis (Tdap) Hepatitis B, Measles, Mumps and Rubella (MMR), Varicelli, Inactivated Polio Vaccine (IPV), Diphtheria, Tetanus and Pertussis (DTaP), Flu for the period of October 1, 2018 - end of March 2019.Organization: Health Canada
March 2024
Req # A-2019-001525
The Clinical Overview, Clinical Summary of Efficacy and Clinical Summary of Safety submitted to Health Canada as part of the Supplemental New Drug Submission (SNDS) (control number: 204690; decision date: 2018-03-29) in respect of TALTZ.Organization: Health Canada
March 2024